396 related articles for article (PubMed ID: 19037107)
21. Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis).
Takada Y
J Biomed Biotechnol; 2012; 2012():136302. PubMed ID: 23125522
[TBL] [Abstract][Full Text] [Related]
22. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
[TBL] [Abstract][Full Text] [Related]
24. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
25. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.
Kobayashi N; Ueno T; Ohashi K; Yamashita H; Takahashi Y; Sakamoto K; Manabe S; Hara S; Takashima Y; Dan T; Pastan I; Miyata T; Kurihara H; Matsusaka T; Reiser J; Nagata M
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F614-26. PubMed ID: 25587125
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
[TBL] [Abstract][Full Text] [Related]
27. M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues.
Puxbaum V; Nimmerfall E; Bäuerl C; Taub N; Blaas PM; Wieser J; Mikula M; Mikulits W; Ng KM; Yeoh GC; Mach L
J Hepatol; 2012 Aug; 57(2):337-43. PubMed ID: 22521359
[TBL] [Abstract][Full Text] [Related]
28. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins α
Romagnuolo R; Scipione CA; Bazzi ZA; Boffa MB; Koschinsky ML
Atherosclerosis; 2018 Aug; 275():11-21. PubMed ID: 29852400
[TBL] [Abstract][Full Text] [Related]
30. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling.
Lin CH; Lin HH; Kuo CY; Kao SH
Oncotarget; 2017 Feb; 8(7):11316-11328. PubMed ID: 28076322
[TBL] [Abstract][Full Text] [Related]
31. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
32. Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.
Ghosh S; Johnson JJ; Sen R; Mukhopadhyay S; Liu Y; Zhang F; Wei Y; Chapman HA; Stack MS
J Biol Chem; 2006 May; 281(19):13021-13029. PubMed ID: 16510444
[TBL] [Abstract][Full Text] [Related]
33. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.
Bass R; Werner F; Odintsova E; Sugiura T; Berditchevski F; Ellis V
J Biol Chem; 2005 Apr; 280(15):14811-8. PubMed ID: 15677461
[TBL] [Abstract][Full Text] [Related]
34. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
Jo M; Takimoto S; Montel V; Gonias SL
Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
[TBL] [Abstract][Full Text] [Related]
35. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
36. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
[TBL] [Abstract][Full Text] [Related]
37. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.
Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H
Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
39. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
40. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
